Dr. Jaster attended the FDA hearing on "Considerations for Potential Future Therapeutic Use of Psychedelic Drugs," and sat down only hours after to give you her unfiltered thoughts.


The hearing took place on September 14, 2026 from 12:30 to 4:30ET. There were two sessions of public comments that featured approximately 80 speakers. The first session focused on provider training, credentialing and patient safety. The second session was focused on access, data collection and standardization.While the hearing is over, the written public comment period is open until 11:59 ET on October 5th.

To submit, visit https://www.federalregister.gov/documents/2026/07/14/2026-14155/considerations-for-potential-future-therapeutic-use-of-psychedelic-drugs-public-hearing-request-for

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör Psychedelic Brain Science. Innehållet i podden är skapat av Psychedelic Brain Science och inte av, eller tillsammans med, Poddtoppen.